• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Schrodinger Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    6/18/25 4:09:48 PM ET
    $SDGR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $SDGR alert in real time by email
    sdgr-20250618
    1540 Broadway24th FloorNew YorkNYFALSE000149097800014909782025-06-182025-06-18

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    ________________________________________
    FORM 8-K
    ________________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): June 18, 2025
    ________________________________________
    Schrodinger, Inc.
    (Exact name of Registrant as Specified in Its Charter)
    ________________________________________
    Delaware001-3920695-4284541
    (State or other jurisdiction of
    incorporation or organization)
    (I.R.S. Employer
    Identification No.)
    (Commission File Number)
    1540 Broadway, 24th Floor
    New York, NY
    10036
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: (212) 295-5800
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    ________________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading
    Symbol(s)
    Name of each exchange on which registered
    Common stock, par value $0.01 per shareSDGRThe Nasdaq Stock Market LLC
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
    Emerging growth company o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

    Item 5.07 Submission of Matters to a Vote of Security Holders.
    At the 2025 Annual Meeting of Stockholders of Schrödinger, Inc. (the “Company”), held on June 18, 2025 (the “Annual Meeting”), the Company’s stockholders voted on the three proposals set forth below. A more detailed description of each proposal is set forth in the Company’s Proxy Statement for the Annual Meeting filed with the Securities and Exchange Commission on April 24, 2025.
    Holders of the Company’s common stock were entitled to one vote per share of common stock on each matter brought before the Annual Meeting. Holders of the Company’s limited common stock were entitled to one vote per share of limited common stock on each matter brought before the Annual Meeting, except that each share of limited common stock was not entitled to vote on the election of directors.
    Proposal 1 – Election of Four Class II Directors
    The Company’s stockholders elected Jeffrey Chodakewitz, Michael Lynton, Nancy A. Thornberry, and Bridget van Kralingen as Class II directors of the board of directors, each to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified. The results of the stockholders’ vote with respect to the election of such Class II directors were as follows:
    Nominee
    Number of Shares of Common Stock FOR
    Number of Shares of Common Stock AGAINST
    Number of Shares of Common Stock ABSTAINING
    BROKER NON-VOTES
    Jeffrey Chodakewitz
    44,010,885633,12427,1157,885,651
    Michael Lynton
    32,354,60512,288,93827,5817,885,651
    Nancy A. Thornberry
    44,012,696612,24746,1817,885,651
    Bridget van Kralingen
    44,203,761440,68426,6797,885,651

    Proposal 2 – Advisory Vote on Executive Compensation
    The Company’s stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers. The results of the stockholders’ non-binding, advisory vote with respect to compensation paid to the Company’s named executive officers were as follows:
    Number of Shares FOR
    Number of Shares AGAINST
    Number of Shares ABSTAINING
    BROKER NON-VOTES
    Common Stock
    41,593,9583,028,65048,5167,885,651
    Limited Common Stock
    9,164,193000
    Total
    50,758,1513,028,65048,5167,885,651


    Proposal 3 – Ratification of the Appointment of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025
    The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of the stockholders’ vote with respect to such ratification were as follows:



    Number of Shares FOR
    Number of Shares AGAINST
    Number of Shares ABSTAINING
    Common Stock
    52,190,272335,20331,300
    Limited Common Stock
    9,164,19300
    Total
    61,354,465335,20331,300





    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
    Schrödinger, Inc.
    Date: June 18, 2025
    By:/s/ Yvonne Tran
    Yvonne Tran
    Executive Vice President and Chief Legal Officer